FDA grants priority review to Bayer's regorafenib
Linkedin

FDA grants priority review to Bayer's regorafenib

New York City : NY : USA | Jun 28, 2012 at 4:38 AM PDT
Source: Fox News
XX XX
Views: Pending
 
Reuters Health regulators granted a priority review for Bayer's colorectal cancer drug regorafenib, potentially speeding up the experimental treatment's route to market. The Food and Drug Administration grants priority reviews to medicines that are considered potentially significant therapeutic... FULL ARTICLE AT Fox News
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.